2
Clinical Trials associated with 177Lu-DOTA-FAPIEfficiency of 177Lu-DOTA-FAPI Therapy in Treatment of Patients With Various Types of Cancer (Primary Locally Advanced or Metastatic Cancers)
Start Date23 Sep 2021 |
Sponsor / Collaborator- |
68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)
This is a Phase I, first-in-human study to evaluate the safety and efficacy of the 68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI theranostic pair in patients with various types of cancer (locally advanced or metastatic cancer).
100 Clinical Results associated with 177Lu-DOTA-FAPI
100 Translational Medicine associated with 177Lu-DOTA-FAPI
100 Patents (Medical) associated with 177Lu-DOTA-FAPI
100 Deals associated with 177Lu-DOTA-FAPI